Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
La Jolla Institute For Allergy & Immunology, United States;
University of California, San Diego, United States;
Sinovac Biotech, China;
University College London, United Kingdom;
Share this article
Cite this article
Nicolas M S Gálvez
Gaspar A Pacheco
Barbara M Schultz
Felipe Melo-González
Jorge A Soto
Luisa F Duarte
Liliana A Gonzalez
Daniela S Rivera
Mariana Ríos
Roslye V Berrios
Yaneisi Vázquez
Daniela Moreno-Tapia
Omar P Vallejos
Catalina A Andrade
Guillermo Hoppe-Elsholz
Carolina Iturriaga
Marcela Urzua
María S Navarrete
Álvaro Rojas
Rodrigo Fasce
Jorge Fernández
Judith Mora
Eugenio Ramirez
Aracelly Gaete-Argel
Mónica Acevedo
Fernando Valiente-Echeverria
Ricardo Soto-Rifo
Daniela Weiskopf
Alba Grifoni
Alessandro Sette
Gang Zeng
Weining Meng
José V Gonzalez-Aramundiz
Marina Johnson
David Goldblatt
Pablo A González
Katia Abarca
Susan M Bueno
Alexis M Kalergis
(2022)
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial